RLYB Stock Analysis: Buy, Sell, or Hold?
RLYB - Rallybio Corporation Common Stock
$8.43
0.03 (0.36%)
▲
5d:
-0.12%
30d:
-19.75%
90d:
+1128.68%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When RLYB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: RLYB shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: RLYB shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: RLYB is currently trading at $8.43, which is considered slightly low relative to its 30-day fair value range of $8.21 to $10.36.
Technical Outlook: Technically, RLYB is in a strong uptrend. Immediate support is located at $7.90, while resistance sits at $9.47.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RLYB is in a strong uptrend. Immediate support is located at $7.90, while resistance sits at $9.47.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$8.21 -
$10.36
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($8.00)
Fair Price Analysis
30-Day Fair Range
$8.21 -
$10.36
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$7.90
Resistance Level
$9.47
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.34
Wall Street Target
$8.00
(-5.1%)
Revenue Growth (YoY)
484.2%
Share & Embed Analysis
Last updated: April 06, 2026 2:04 AM ET
Data refreshes hourly during market hours. Next update: 3:04 AM
Data refreshes hourly during market hours. Next update: 3:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RLYB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jonathan I Lieber
SELL
789 shares
2026-02-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 53 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 52 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$33 | 61 BUY |
